Increased CSF levels of the biomarkers NFL, Ng, YKL-40, and VILIP-1 have been found in AD and correlate with neurodegeneration, suggesting a potential use as a surrogate marker of synaptic and neuronal loss [3], [22], [23], [24]. This evidence concerns the gene NRGN and Alzheimer disease.